Skye Bioscience, Inc. Increase (Decrease) in Other Current Liabilities
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Other Current Liabilities of -$1.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-08-14
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for the quarter ending 2026-06-30 was -$2.79M, a 298.47% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for the quarter ending 2026-03-31 was $1.21M, a 458.08% increase year-over-year.
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was $292.43K.
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was $394.35K, a 57.28% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for fiscal 2025 was $2.31M.
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for fiscal 2024 was -$344.35K.
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for fiscal 2023 was -$493.47K.
- Skye Bioscience, Inc. increase (decrease) in other current liabilities for fiscal 2022 was -$1.84M, a 1204.45% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 3 month as first filed | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 6 month as first filed | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month | Increase (Decrease) in Other Current Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.58M 10-Q · filed 2026-08-14 | -$1.29M derived: sum of 3 quarters · filed 2026-08-14 | -$892.76K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-11 | $1.50M derived: sum of 2 quarters · filed 2026-05-11 | $1.90M derived: sum of 3 quarters · filed 2026-05-11 | $3.30M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $292.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $686.78K derived: sum of 2 quarters · filed 2026-03-10 | $2.09M derived: sum of 3 quarters · filed 2026-08-14 | $2.31M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $394.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.80M derived: sum of 2 quarters · filed 2026-08-14 | $2.02M 10-Q · filed 2025-11-10 | $562.49K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.62M 10-Q · filed 2026-08-14 | $168.13K derived: sum of 3 quarters · filed 2026-08-14 | $1.09M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $216.70K 10-Q · filed 2026-05-11 | -$1.24M derived: sum of 2 quarters · filed 2026-05-11 | -$313.89K derived: sum of 3 quarters · filed 2026-05-11 | -$211.32K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$530.59K derived: sum of 2 quarters · filed 2026-03-10 | -$428.02K derived: sum of 3 quarters · filed 2026-03-10 | -$344.35K 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $923.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.03M derived: sum of 2 quarters · filed 2025-11-10 | $1.11M 10-Q · filed 2025-11-10 | $1.19M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $102.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $186.24K 10-Q · filed 2025-08-07 | $263.24K derived: sum of 3 quarters · filed 2025-08-07 | -$278.23K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $83.67K 10-Q · filed 2025-05-08 | $85.04K 10-Q · filed 2024-05-10 | $160.67K derived: sum of 2 quarters · filed 2025-05-08 | -$380.80K derived: sum of 3 quarters · filed 2025-05-08 | -$277.14K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$464.48K derived: sum of 2 quarters · filed 2025-03-20 | -$360.82K derived: sum of 3 quarters · filed 2025-03-20 | -$493.47K 10-K · filed 2025-03-20 | -$493.47K 10-K · filed 2024-03-22 | ||
| 2023-09-30 | -$541.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$437.82K derived: sum of 2 quarters · filed 2024-11-07 | -$570.47K 10-Q · filed 2024-11-07 | -$2.41M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $103.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$29.00K 10-Q · filed 2024-08-09 | -$1.87M derived: sum of 3 quarters · filed 2024-08-09 | -$1.83M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$132.65K 10-Q · filed 2024-05-10 | -$132.65K 10-Q · filed 2023-05-12 | -$1.97M derived: sum of 2 quarters · filed 2024-05-10 | -$1.94M derived: sum of 3 quarters · filed 2024-05-10 | -$1.99M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$1.81M derived: sum of 2 quarters · filed 2024-03-22 | -$1.85M derived: sum of 3 quarters · filed 2024-03-22 | -$1.84M 10-K · filed 2024-03-22 | |||
| 2022-09-30 | $35.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$13.88K derived: sum of 2 quarters · filed 2023-11-14 | $1.38K 10-Q · filed 2023-11-14 | -$33.95K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$49.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$33.76K 10-Q · filed 2023-08-07 | -$69.09K derived: sum of 3 quarters · filed 2023-08-07 | -$225.05K derived: sum of 4 quarters · filed 2023-08-07 | |||
| 2022-03-31 | $15.26K 10-Q · filed 2023-05-12 | -$20.07K derived: sum of 2 quarters · filed 2023-05-12 | -$176.02K derived: sum of 3 quarters · filed 2023-05-12 | $60.50K derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | -$35.33K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$191.29K derived: sum of 2 quarters · filed 2023-03-31 | $45.23K derived: sum of 3 quarters · filed 2023-03-31 | $166.53K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$155.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $80.56K derived: sum of 2 quarters · filed 2022-11-14 | $201.86K 10-Q · filed 2022-11-14 | $197.14K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $236.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $357.82K 10-Q · filed 2022-08-15 | $353.10K derived: sum of 3 quarters · filed 2022-08-15 | $385.02K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $121.30K 10-Q · filed 2022-05-06 | $116.58K derived: sum of 2 quarters · filed 2022-05-06 | $148.50K derived: sum of 3 quarters · filed 2022-05-06 | -$49.48K derived: sum of 4 quarters · filed 2022-05-06 | |||
| 2020-12-31 | -$4.72K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $27.21K derived: sum of 2 quarters · filed 2022-03-28 | -$170.78K derived: sum of 3 quarters · filed 2022-03-28 | -$161.29K 10-K · filed 2022-03-28 | |||
| 2020-09-30 | $31.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$166.06K derived: sum of 2 quarters · filed 2021-11-10 | -$156.58K 10-Q · filed 2021-11-10 | -$65.10K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$197.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$188.50K 10-Q · filed 2021-08-06 | $6.48K 10-Q · filed 2020-08-13 | -$97.03K derived: sum of 3 quarters · filed 2021-08-06 | -$145.05K derived: sum of 4 quarters · filed 2021-08-06 | ||
| 2020-03-31 | $9.48K 10-Q · filed 2021-05-07 | -$15.06K 10-Q · filed 2020-05-08 | $100.96K derived: sum of 2 quarters · filed 2021-05-07 | $52.94K derived: sum of 3 quarters · filed 2021-05-07 | $208.29K derived: sum of 4 quarters · filed 2021-05-07 | ||
| 2019-12-31 | $91.48K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $43.45K derived: sum of 2 quarters · filed 2021-03-02 | $198.81K derived: sum of 3 quarters · filed 2021-03-02 | $225.94K 10-K · filed 2021-03-02 | |||
| 2019-09-30 | -$48.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $107.33K derived: sum of 2 quarters · filed 2020-11-06 | $134.47K 10-Q · filed 2020-11-06 | $172.77K derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $155.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $182.49K 10-Q · filed 2020-08-13 | $220.79K derived: sum of 3 quarters · filed 2020-08-13 | $251.87K derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $27.13K 10-Q · filed 2020-05-08 | $65.43K derived: sum of 2 quarters · filed 2020-05-08 | $96.51K derived: sum of 3 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $38.30K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $69.38K derived: sum of 2 quarters · filed 2020-03-23 | -$10.11K 10-K · filed 2020-03-23 | ||||
| 2018-09-30 | $31.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$48.41K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | -$79.49K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |